Article Type
Changed
Thu, 03/28/2019 - 16:00
Display Headline
Oncologist compensation deserves evidence-based scrutiny and analysis

As community-based oncology practices have faced continued cutbacks in reimbursements under the Medicare Prescription Drug, Improvement, and Modernization Act and now through sequestration, many have had to close satellite sites, cut back on their supportive services, join networks – where possible – or hospitals or health systems, and scramble to engage payers in rethinking payment models. They have done so not only to cover their costs for the technological outlay, staffing, and other overheads necessary for them to provide quality oncology care, but also to ensure competitive compensation packages for their teams of highly trained, specialized physicians, midlevel practitioners, and nursing and administrative staff…

*Click on the link to the left for a PDF of the full article.  

Article PDF
Author and Disclosure Information

Publications
Topics
Legacy Keywords
oncologist compensation, MMA, Medicare Prescription Drug, Improvement, and Modernization Act, 340B program

Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

As community-based oncology practices have faced continued cutbacks in reimbursements under the Medicare Prescription Drug, Improvement, and Modernization Act and now through sequestration, many have had to close satellite sites, cut back on their supportive services, join networks – where possible – or hospitals or health systems, and scramble to engage payers in rethinking payment models. They have done so not only to cover their costs for the technological outlay, staffing, and other overheads necessary for them to provide quality oncology care, but also to ensure competitive compensation packages for their teams of highly trained, specialized physicians, midlevel practitioners, and nursing and administrative staff…

*Click on the link to the left for a PDF of the full article.  

As community-based oncology practices have faced continued cutbacks in reimbursements under the Medicare Prescription Drug, Improvement, and Modernization Act and now through sequestration, many have had to close satellite sites, cut back on their supportive services, join networks – where possible – or hospitals or health systems, and scramble to engage payers in rethinking payment models. They have done so not only to cover their costs for the technological outlay, staffing, and other overheads necessary for them to provide quality oncology care, but also to ensure competitive compensation packages for their teams of highly trained, specialized physicians, midlevel practitioners, and nursing and administrative staff…

*Click on the link to the left for a PDF of the full article.  

Publications
Publications
Topics
Article Type
Display Headline
Oncologist compensation deserves evidence-based scrutiny and analysis
Display Headline
Oncologist compensation deserves evidence-based scrutiny and analysis
Legacy Keywords
oncologist compensation, MMA, Medicare Prescription Drug, Improvement, and Modernization Act, 340B program

Legacy Keywords
oncologist compensation, MMA, Medicare Prescription Drug, Improvement, and Modernization Act, 340B program

Article Source

PURLs Copyright

Inside the Article

Article PDF Media